These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 30914860)

  • 1. Metabolomics Profiling on Different Stages of Colorectal Cancer: A Systematic Review.
    Yusof HM; Ab-Rahim S; Suddin LS; Saman MSA; Mazlan M
    Malays J Med Sci; 2018 Sep; 25(5):16-34. PubMed ID: 30914860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Global serum metabolomics profiling of colorectal cancer.
    Hashim NAA; Ab-Rahim S; Suddin LS; Saman MSA; Mazlan M
    Mol Clin Oncol; 2019 Jul; 11(1):3-14. PubMed ID: 31289671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterizing metabolic changes in human colorectal cancer.
    Williams MD; Zhang X; Park JJ; Siems WF; Gang DR; Resar LM; Reeves R; Hill HH
    Anal Bioanal Chem; 2015 Jun; 407(16):4581-95. PubMed ID: 25943258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Review of GC-Based Analysis of Non-Invasive Biomarkers of Colorectal Cancer and Related Pathways.
    Monedeiro F; Monedeiro-Milanowski M; Ligor T; Buszewski B
    J Clin Med; 2020 Oct; 9(10):. PubMed ID: 33019642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Application of Metabolomics in Recent Colorectal Cancer Studies: A State-of-the-Art Review.
    Gold A; Choueiry F; Jin N; Mo X; Zhu J
    Cancers (Basel); 2022 Jan; 14(3):. PubMed ID: 35158992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolomics for biomarker discovery in the diagnosis, prognosis, survival and recurrence of colorectal cancer: a systematic review.
    Zhang F; Zhang Y; Zhao W; Deng K; Wang Z; Yang C; Ma L; Openkova MS; Hou Y; Li K
    Oncotarget; 2017 May; 8(21):35460-35472. PubMed ID: 28389626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a Correlative Strategy To Discover Colorectal Tumor Tissue Derived Metabolite Biomarkers in Plasma Using Untargeted Metabolomics.
    Wang Z; Cui B; Zhang F; Yang Y; Shen X; Li Z; Zhao W; Zhang Y; Deng K; Rong Z; Yang K; Yu X; Li K; Han P; Zhu ZJ
    Anal Chem; 2019 Feb; 91(3):2401-2408. PubMed ID: 30580524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 1H HR-MAS NMR spectroscopy of tumor-induced local metabolic "field-effects" enables colorectal cancer staging and prognostication.
    Jiménez B; Mirnezami R; Kinross J; Cloarec O; Keun HC; Holmes E; Goldin RD; Ziprin P; Darzi A; Nicholson JK
    J Proteome Res; 2013 Feb; 12(2):959-68. PubMed ID: 23240862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An integrated proteomics and metabolomics approach for defining oncofetal biomarkers in the colorectal cancer.
    Ma Y; Zhang P; Wang F; Liu W; Yang J; Qin H
    Ann Surg; 2012 Apr; 255(4):720-30. PubMed ID: 22395091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolomics Analysis in Serum from Patients with Colorectal Polyp and Colorectal Cancer by
    Gu J; Xiao Y; Shu D; Liang X; Hu X; Xie Y; Lin D; Li H
    Dis Markers; 2019; 2019():3491852. PubMed ID: 31089393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recognition of early and late stages of bladder cancer using metabolites and machine learning.
    Kouznetsova VL; Kim E; Romm EL; Zhu A; Tsigelny IF
    Metabolomics; 2019 Jun; 15(7):94. PubMed ID: 31222577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Global and targeted serum metabolic profiling of colorectal cancer progression.
    Long Y; Sanchez-Espiridion B; Lin M; White L; Mishra L; Raju GS; Kopetz S; Eng C; Hildebrandt MAT; Chang DW; Ye Y; Liang D; Wu X
    Cancer; 2017 Oct; 123(20):4066-4074. PubMed ID: 28640361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolomics and metabolic pathway networks from human colorectal cancers, adjacent mucosa, and stool.
    Brown DG; Rao S; Weir TL; O'Malia J; Bazan M; Brown RJ; Ryan EP
    Cancer Metab; 2016; 4():11. PubMed ID: 27275383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NMR-based metabolomic techniques identify potential urinary biomarkers for early colorectal cancer detection.
    Wang Z; Lin Y; Liang J; Huang Y; Ma C; Liu X; Yang J
    Oncotarget; 2017 Dec; 8(62):105819-105831. PubMed ID: 29285295
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Lin Y; Ma C; Bezabeh T; Wang Z; Liang J; Huang Y; Zhao J; Liu X; Ye W; Tang W; Ouyang T; Wu R
    Int J Cancer; 2019 Sep; 145(6):1679-1689. PubMed ID: 30720869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic profiling of human colorectal cancer using high-resolution magic angle spinning nuclear magnetic resonance (HR-MAS NMR) spectroscopy and gas chromatography mass spectrometry (GC/MS).
    Chan EC; Koh PK; Mal M; Cheah PY; Eu KW; Backshall A; Cavill R; Nicholson JK; Keun HC
    J Proteome Res; 2009 Jan; 8(1):352-61. PubMed ID: 19063642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum metabolomics analysis for early detection of colorectal cancer.
    Uchiyama K; Yagi N; Mizushima K; Higashimura Y; Hirai Y; Okayama T; Yoshida N; Katada K; Kamada K; Handa O; Ishikawa T; Takagi T; Konishi H; Kuriu Y; Nakanishi M; Otsuji E; Itoh Y; Naito Y
    J Gastroenterol; 2017 Jun; 52(6):677-694. PubMed ID: 27650200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for colon cancer: A test for occult blood.
    Khakimov N; Khasanova G; Ershova K; Gibadullina L; Vetkina T; Lobisheva G; Chumakova A
    Int J Risk Saf Med; 2015; 27 Suppl 1():S110-1. PubMed ID: 26639687
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.